Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH study

by Paly VF, Naya I, Gunsoy NB, Driessen MT, Risebrough N, Briggs A, Ismaila AS
Published 2019-05-01

Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol

by Singh D, Maleki-Yazdi MR, Tombs L, Iqbal A, Fahy WA, Naya I
Published 2016-06-01